ImmunOs Therapeutics AG Raises $11 Million and Further Strengthens Investor Base Existing investors and new investor Double Point Ventures join forces to support ImmunOs TherapeuticsInvestment secures funding of ongoing promising clinical trial of IOS-1002 in solid cancers ...